Jakob Dupont
2013 - OncoMed Pharmaceuticals
In 2013, Jakob Dupont earned a total compensation of $1.1M as Senior Vice President & Chief Medical Officer at OncoMed Pharmaceuticals, a 141% increase compared to previous year.
Compensation breakdown
| Bonus | $125,000 |
|---|---|
| Non-Equity Incentive Plan | $130,559 |
| Option Awards | $480,359 |
| Salary | $362,664 |
| Total | $1,098,582 |
Dupont received $480.4K in option awards, accounting for 44% of the total pay in 2013.
Dupont also received $125K in bonus, $130.6K in non-equity incentive plan and $362.7K in salary.
Rankings
In 2013, Jakob Dupont's compensation ranked 6,190th out of 12,286 executives tracked by ExecPay. In other words, Dupont earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,190 out of 12,286 | 50th |
Division Manufacturing | 2,158 out of 4,612 | 53rd |
Major group Chemicals And Allied Products | 638 out of 1,462 | 56th |
Industry group Drugs | 461 out of 1,156 | 60th |
Industry Pharmaceutical Preparations | 369 out of 890 | 59th |
Source: SEC filing on April 24, 2015.
Dupont's colleagues
We found two more compensation records of executives who worked with Jakob Dupont at OncoMed Pharmaceuticals in 2013.